Literature DB >> 6603932

Immunological study of IgA deficiency during anticonvulsant therapy in epileptic patients.

H Matsuoka, J Okada, T Takahashi, M Matsuoka, C Sato, S Torii.   

Abstract

Of 10 epileptic children with IgA deficiency, one showed normal IgA synthesis and secretion on in vitro pokeweed mitogen (PWM) stimulated lymphocyte culture in contrast to IgA deficiency in vivo, two showed IgA synthesis in cytoplasm without any release of IgA into the supernatant and seven failed to synthesize IgA. Co-cultures with allogeneic T or B cells in various combinations with PWM showed intrinsic IgA-B cell defect without T cell defect in two of the second group affected at IgA secretion and in five of the third group, and intrinsic IgA-B defect with dysfunction of T cells in two of the third group. Thus, the IgA deficiency in these epileptic patients was demonstrated to be heterogenous.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603932      PMCID: PMC1535678     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency.

Authors:  T A Waldmann; S Broder; R Krakauer; M Durm; B Meade; C Goldman
Journal:  Trans Assoc Am Physicians       Date:  1976

2.  Immunoglobulin abnormalities in epileptic patients treated with diphenylhydantoin.

Authors:  S Yabuki; K Nakaya
Journal:  Folia Psychiatr Neurol Jpn       Date:  1976

3.  Suppressor cells and IgA deficiency.

Authors:  J S Atwater; T B Tomasi
Journal:  Clin Immunol Immunopathol       Date:  1978-03

4.  Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants.

Authors:  R A Shakir; P O Behan; H Dick; D G Lambie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-04       Impact factor: 10.154

5.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

6.  Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.

Authors:  T C Sorrell; I J Forbes
Journal:  Clin Exp Immunol       Date:  1975-05       Impact factor: 4.330

7.  IgA deficiency, epilepsy, and phenytoin treatment.

Authors:  J Seager; D L Jamison; J Wilson; A R Hayward; J F Soothill
Journal:  Lancet       Date:  1975-10-04       Impact factor: 79.321

8.  Delayed cutaneous hypersensitivity in children with severe multiple handicaps treated with phenytoin.

Authors:  A Higashi; I Matsuda; S Sinosuka; H Ohtsuka; F Endo; T Maeda; T Ikeda; S Miyoshino
Journal:  Eur J Pediatr       Date:  1978-12-01       Impact factor: 3.183

9.  Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.

Authors:  J A Aarli
Journal:  Acta Neurol Scand       Date:  1976-11       Impact factor: 3.209

10.  Salivary and plasma IgA of seizure subjects receiving phenytoin.

Authors:  Q T Smith; M J Hamilton; M H Biros; B L Pihlstrom
Journal:  Epilepsia       Date:  1979-02       Impact factor: 5.864

View more
  5 in total

Review 1.  Immunoglobulins in epilepsy.

Authors:  J A Aarli
Journal:  Springer Semin Immunopathol       Date:  1985

2.  Presence of immunoglobulin (Ig) M and IgG double isotype-bearing cells and defect of switch recombination in hyper IgM immunodeficiency.

Authors:  Y Akahori; Y Kurosawa; Y Kamachi; S Torii; H Matsuoka
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  IgG subclasses in epileptic patients treated with phenytoin.

Authors:  N E Gilhus; T Lea
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

4.  In vitro analysis of lymphocyte functions in common variable immunodeficiency: heterogeneity in B-cell defects.

Authors:  H Matsuoka; J Okada; T Takahashi; T Mizuno; M Matsuoka; I Tsuge; S Torii
Journal:  Eur J Pediatr       Date:  1986-09       Impact factor: 3.183

Review 5.  Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Authors:  Jacqueline Kerr; Isabella Quinti; Martha Eibl; Helen Chapel; Peter J Späth; W A Carrock Sewell; Abdulgabar Salama; Ivo N van Schaik; Taco W Kuijpers; Hans-Hartmut Peter
Journal:  Front Immunol       Date:  2014-12-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.